SINGLE USE BIOPROCESSING MARKET

1. Single Use Biporocessing Market Top Key Players - G&G Technologies, Solida Biotech GmbH, Satake Chemical Equipment Mfg. Ltd., Stobbe Pharma GmbH, General Electric Company, Corning, Entegris, Avantor ,CESCO Bioengineering Co. Ltd. and Cellexus According to a new report published by xResearch, titled, “Single Use Bioprocessing Market 2022- Industry Insights, Trends, Opportunity & Forecast, 2021–2030,” the global single use bioprocessing market size is anticipated to witness exponential growth during the forecast period i.e. 2022-2030. Factors such as the escalating number of manufacturers offering robust disposables for commercial manufacturing of biopharmaceuticals, the proliferating adoption of disposable technologies attributable to the low risk of product cross-contamination of SUB technologies, and the soaring demand for biopharmaceuticals & energy efficiency across the globe are among the predominant factors contributing towards the growth of the global single use bioprocessing market. Download Request for Sample@ https://www.xresearch.biz/request-sample- pages/single-use-biporocessing-market According to method, the filtration segment accounted for largest market share in the global single use bioprocessing market 2021 followed by the storage segment. The segment is expected to retain its hold in the market over the forecast period. According to product, the simple and peripheral elements segment dominated the global single use bioprocessing market by acquiring a market share of 48.0% in 2021. The segment is projected to further maintain its lead in the market over the forecast period. However, the apparatus and plants segment is predicted to register the highest CAGR in the market during the forecast period. According to workflow, the upstream segment accounted for 58.0% market share and led the global single use bioprocessing market in 2021. According to end-user, the biopharmaceutical companies segment acquired a market share of 60.0% and led the global single-use bioprocessing market in 2021. The segment is anticipated to further retain its dominance in the market over the forecast

2. period. The burgeoning popularity of disposables amongst CMOs and the rapidly rising number of investments by biomanufacturers for the expansion of their manufacturing capabilities to meet the ever-changing consumer demands are attributable to the segment’s growth. Geographically, the North American region accounted for 34.5% of market share and commanded the global single use bioprocessing market in 2021 followed by Europe. This trend is expected to continue over the forecast period of 2022-2030. The U.S. is the largest and the fastest growing single use bioprocessing market in the region. The Asia Pacific region is expected register growth at the highest CAGR in the global single use bioprocessing market during the forecast period of 2022-2030. Countries such as India, China and Japan are among the primary contributors to the growth of this market in the region. Some of the major single use bioprocessing companies profiled in the report include G&G Technologies, Solida Biotech GmbH, Satake Chemical Equipment Mfg. Ltd., Stobbe Pharma GmbH, General Electric Company, Corning, Entegris, Avantor ,CESCO Bioengineering Co. Ltd. and Cellexus. The global single use bioprocessing market is segmented into product, method, application, workflow, end user and region. Based on product, the market is bifurcated into simple & peripheral elements, apparatus & plants and work equipment. The simple & peripheral segment is further categorized into bags; tubing, filters, connectors, & transfer sytems; sampling systems; probes & sensors and others. The probes & sensors sub-segment is further categorized into pH sensor, oxygen sensors, pressure sensors, temperature sensors, conductivity sensors flow sensors and other sensors. The apparatus & plants segment is further categorized into bioreactors; filtration system; mixing, storage, & filling systems; chromatography systems, pumps and others. The bioreactors sub-segment is further categorized by capacity into up to 1000L; above 1000L to 2000L and above 2000L. The work equipment segment is further categorized into cell culture system, syringes and others. Based on method, it is classified into filtration, storage, cell culture, mixing and purification.

3. Based on application, it is classified into monoclonal antibody production, vaccine production, plant cell cultivation, patient specific cell therapies and other applications. Based on workflow, it is classified into upstream, fermentation and downstream. Based on end user, it is classified into biopharmaceutical companies, contract research organizations and contract manufacturing organizations (CROs & CMOs) and life science R&D companies and academic & research institutes. The global single use bioprocessing market is analyzed across North America (U.S. & Canada), Europe (Germany, United Kingdom, France, Italy, Spain, Russia, and Rest of Europe), Asia Pacific (China, India, Japan, South Korea, Indonesia, Thailand, Australia, New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and the Rest of Latin America) and Middle East & Africa (GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, and Rest of Middle East & Africa). Key Insights of Single Use Bioprocessing Market  On the basis of method, the filtration segment accounted for largest market share in the global single use bioprocessing market 2021 followed by the storage segment and is expected to further retain its hold in the market over the forecast period.  On the basis of product, the simple and peripheral elements segment dominated the global single use bioprocessing market by acquiring a market share of 48.0% in 2021. The segment is projected to further maintain its lead in the market over the forecast period. The apparatus and plants segment is predicted to register the highest CAGR in the market during the forecast period.  On the basis of workflow, the upstream segment accounted for 58.0% market share and led the global single use bioprocessing market in 2021.  On the basis of end-user, the biopharmaceutical companies segment acquired a market share of 60.0% and led the global single-use bioprocessing market in 2021 and is anticipated to further retain its dominance in the market over the forecast period.  On the basis of region, North America accounted for 34.5% of market share and commanded the global single use bioprocessing market in 2021 followed by Europe. This trend is expected to continue over the forecast period of 2022-2030.  On the basis of region, Asia Pacific is expected register growth at the highest CAGR in the global single use bioprocessing market during the forecast period of 2022-2030.

4. Read More Information: https://www.xresearch.biz/shop/single-use- biporocessing-market About Us:- xResearch is a market research and consulting organization that uses unique data, expert analysis, and new technologies to create trusted intelligence on industries. Our research is focused on delivering an informed and impartial view on essential market data of industry, and it is primarily driven by an in-depth study covering the following parameters: Market Sizing and Forecasting, Market Segmentation, Competitive Analysis, Strategic Assessment and Business Modelling. Contact: Company Name: xResearch Contact Person: James Lin Email: sales@xresearch.biz Phone: +1 718-618-4545